105 related articles for article (PubMed ID: 27064585)
1. Heme oxygenase-1 in type 2 diabetes: from cell first-line defense to early marker of diabetic nephropathy.
Pagnin E; Maiolino G; Calò LA
Minerva Med; 2016 Apr; 107(2):123-4. PubMed ID: 27064585
[No Abstract] [Full Text] [Related]
2. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patients.
Al-Rubeaan K; Siddiqui K; Al-Ghonaim MA; Youssef AM; Al-Sharqawi AH; AlNaqeb D
Sci Rep; 2017 Jun; 7(1):2684. PubMed ID: 28577020
[TBL] [Abstract][Full Text] [Related]
4. Determination of glomerular NAG fraction in urine samples of patients with diabetic nephropathy using the NAG test kit.
Saitoh A; Tomino Y; Yokoyama K; Kiyatake I; Fujito K; Koide H
Nephron; 1992; 61(1):114. PubMed ID: 1528331
[No Abstract] [Full Text] [Related]
5. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
Wang QY; Chen FQ
Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
[TBL] [Abstract][Full Text] [Related]
6. Urinary N-acetyl-beta-glucosaminidase excretion in non-insulin-dependent diabetes mellitus: relation with diabetic nephropathy.
Pérez-Blanco FJ; Sabatel-Hernández G; Cantero-Hinojosa J; Rodriguez-Cuartero A
Clin Nephrol; 1998 Feb; 49(2):132-4. PubMed ID: 9524787
[No Abstract] [Full Text] [Related]
7. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
[TBL] [Abstract][Full Text] [Related]
8. Soluble CD36 in plasma and urine: a plausible prognostic marker for diabetic nephropathy.
Shiju TM; Mohan V; Balasubramanyam M; Viswanathan P
J Diabetes Complications; 2015 Apr; 29(3):400-6. PubMed ID: 25619588
[TBL] [Abstract][Full Text] [Related]
9. Fighting diabetic kidney disease. The best defense is a good offense--take action now to prevent kidney disease.
Hirsch IB
Diabetes Forecast; 2002 Feb; 55(2):68-70. PubMed ID: 14959672
[No Abstract] [Full Text] [Related]
10. Urinary platelet-derived growth factor-BB as an early marker of nephropathy in patients with type 2 diabetes: an Egyptian study.
Bessa SS; Hussein TA; Morad MA; Amer AM
Ren Fail; 2012; 34(6):670-5. PubMed ID: 22486214
[TBL] [Abstract][Full Text] [Related]
11. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
[TBL] [Abstract][Full Text] [Related]
12. Diabetic nephropathy: is it always there? Assumptions, weaknesses and pitfalls in the diagnosis.
Ioannou K
Hormones (Athens); 2017 Oct; 16(4):351-361. PubMed ID: 29518755
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers for early diagnosis of type 2 diabetic nephropathy: a study based on an integrated biomarker system.
Huang M; Liang Q; Li P; Xia J; Wang Y; Hu P; Jiang Z; He Y; Pang L; Han L; Wang Y; Luo G
Mol Biosyst; 2013 Aug; 9(8):2134-41. PubMed ID: 23719966
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of urine dipstick test for microalbuminuria in type 2 diabetes mellitus patients.
Krairittichai U; Potisat S; Jongsareejit A; Sattaputh C
J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S6-10. PubMed ID: 21717871
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of 8-oxo-7, 8-dihydro-2'-deoxyguanosine as a predictor of the development of diabetic nephropathy.
Hinokio Y; Suzuki S; Hirai M; Suzuki C; Suzuki M; Toyota T
Diabetologia; 2002 Jun; 45(6):877-82. PubMed ID: 12107732
[TBL] [Abstract][Full Text] [Related]
16. Increased urinary excretions of immunoglobulin g, ceruloplasmin, and transferrin predict development of microalbuminuria in patients with type 2 diabetes.
Narita T; Hosoba M; Kakei M; Ito S
Diabetes Care; 2006 Jan; 29(1):142-4. PubMed ID: 16373913
[No Abstract] [Full Text] [Related]
17. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients.
Bolignano D; Lacquaniti A; Coppolino G; Donato V; Fazio MR; Nicocia G; Buemi M
Kidney Blood Press Res; 2009; 32(2):91-8. PubMed ID: 19321980
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy.
Mise K; Hoshino J; Ueno T; Hazue R; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
Diabetes Metab Res Rev; 2015 Sep; 31(6):572-81. PubMed ID: 25533683
[TBL] [Abstract][Full Text] [Related]
19. [Kidney lesions in non-insulin dependent diabetes mellitus].
Georgadze ZO; Balabolkin MI; Mamaeva GG; Liudina LI; Mishchenko BP; Arbuzova MI
Klin Med (Mosk); 1995; 73(6):21-2. PubMed ID: 8691771
[TBL] [Abstract][Full Text] [Related]
20. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
